# Alvotech Ordinary Shares (ALVO)

Alvotech's stock faces significant decline following an FDA Complete Response Letter and lowered FY25 guidance. Negative social media sentiment and recent downgrades are exacerbating the downward pressure.

### About Alvotech Ordinary Shares
Alvotech Ordinary Shares (ALVO) is a publicly traded stock in the healthcare sector, focused on developing and manufacturing biosimilar medicines.  
Alvotech Ordinary Shares uses the ticker $ALVO for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- Alvotech Ordinary Shares (ALVO) trading volume is up 25.96% from the previous week.
- Alvotech Ordinary Shares (ALVO) social dominance is up 200% from the previous month.
- Alvotech Ordinary Shares (ALVO) Galaxy Score™ is up 52.94% from the previous week.
- Alvotech Ordinary Shares (ALVO) engagements is up 20.15% from the previous week.
- Alvotech Ordinary Shares (ALVO) mentions is up 67.86% from the previous week.

### Price: $4.60
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$alvo/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$alvo/time-series/close.tsv)  
The stock price has declined significantly due to an FDA Complete Response Letter and lowered FY25 guidance, exacerbated by negative social media sentiment and recent financial institution downgrades. Analyst downgrades further pressured the stock.  

24-Hour: -1.49%
7-Day: -9.38%
30-Day: -5.69%

1-Year High: $13 on 2025-02-15  
1-Year Low: $4.60 on 2026-01-06  
  
  
### AltRank: [-----]
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$alvo/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$alvo/time-series/alt_rank.tsv)  
Alvotech Ordinary Shares (ALVO) is currently AltRank #2,435 based on combined combined social and market metrics
Daily Average: [-----]  
[--] Week: [-----] +355  
[--] Month: [-----] +431  
[--] Months: [-----] +1,740  
[--] Year: [-----] +1,179  
1-Year High: [-----] on 2026-01-26  
1-Year Low: [--] on 2025-12-20  
  
  
### Galaxy Score: [-----]
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$alvo/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$alvo/time-series/galaxy_score.tsv)  
Current Value: [-----]  
Daily Average: [--]  
[--] Week: [--] +9  
[--] Month: [--] [---]  
[--] Months: [--] [---]  
[--] Year: [--] [---]  
1-Year High: [--] on 2025-09-23  
1-Year Low: [--] on 2026-01-06  
  
  
### Engagements: [---] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$alvo/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$alvo/time-series/interactions.tsv)  
Current Value: [---]  
Daily Average: [-----]  
[--] Week: [-----] +20%  
[--] Month: [------] -22%  
[--] Months: [-------] -37%  
[--] Year: [---------] -42%  
1-Year High: [-------] on 2025-08-13  
1-Year Low: [--] on 2026-01-14  

Engagements by network (24h):
X: [---]
Reddit: [--]
YouTube: [--]

  
  
### Mentions: [--] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$alvo/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$alvo/time-series/posts_active.tsv)  
Current Value: [--]  
Daily Average: [--]  
[--] Week: [--] +68%  
[--] Month: [---] +21%  
[--] Months: [-----] -18%  
[--] Year: [-----] +82%  
1-Year High: [---] on 2025-06-30  
1-Year Low: [--] on 2026-01-02  

Mentions by network (24h):
X: [--]
Reddit: [--]
YouTube: [--]

  
  
### Creators: [--] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$alvo/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$alvo/time-series/contributors_active.tsv)  
[--] unique social accounts have posts mentioning Alvotech Ordinary Shares (ALVO) in the last [--] hours which is up 33% from [--] in the previous [--] hours
Daily Average: [--]  
[--] Week: [--] +9.50%  
[--] Month: [--] +14%  
[--] Months: [---] -48%  
[--] Year: [-----] +127%  
1-Year High: [---] on 2025-06-30  
1-Year Low: [--] on 2026-01-02  

The most influential creators that mention Alvotech Ordinary Shares in the last [--] hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@goldchart2](/creator/twitter/goldchart2)           | [--]    | [---]       | [--]    | [---]         |
| [@NightOwlBiotech](/creator/twitter/NightOwlBiotech) | [--]    | [-----]     | [--]     | [---]         |
| [@doepke_michel](/creator/twitter/doepke_michel)     | [--]    | [------]    | [--]     | [--]          |

[View More](/list/creators/$alvo/100)
  
  
### Sentiment: 100%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$alvo/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$alvo/time-series/sentiment.tsv)  
Current Value: 100%  
Daily Average: 71%  
[--] Week: 100% no change  
[--] Month: 100% +43%  
[--] Months: 100% +25%  
[--] Year: 100% +78%  
1-Year High: 100% on 2025-03-18  
1-Year Low: 8% on 2025-04-11  

Most Supportive Themes:
- Positive Social Media Sentiment: (50%) The stock price has seen a significant decline due to an FDA Complete Response Letter and lowered FY25 guidance, exacerbated by negative social media sentiment and recent financial institution downgrades.
  
Most Critical Themes:
- FDA Complete Response Letter: (40%) The stock price has declined significantly due to an FDA Complete Response Letter and lowered FY25 guidance, exacerbated by negative social media sentiment and recent financial institution downgrades.
- Lowered FY25 Guidance: (30%) The stock price has declined significantly due to an FDA Complete Response Letter and lowered FY25 guidance, exacerbated by negative social media sentiment and recent financial institution downgrades.
- Financial Institution Downgrades: (30%) The stock price has declined significantly due to an FDA Complete Response Letter and lowered FY25 guidance, exacerbated by negative social media sentiment and recent financial institution downgrades.
  
  
  
### Social Dominance: 0.00171%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$alvo/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$alvo/time-series/social_dominance.tsv)  
Current Value: 0.00171%  
Daily Average: 0.0059%  
[--] Week: 0.00167% +0.00097%  
[--] Month: 0.0027% +0.0018%  
[--] Months: 0.0027% -0.011%  
[--] Year: 0.0027% -0.0048%  
1-Year High: 0.037% on 2025-06-29  
1-Year Low: 0.0004% on 2026-01-02  
  
  
### Market Dominance: 0.00164%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$alvo/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$alvo/time-series/market_dominance.tsv)  
Current Value: 0.00164%  
Daily Average: 0%  
1-Year High: 0.129% on 2025-03-14  
1-Year Low: 0.00164% on 2026-02-14  
  
  
### Market Cap: $1,445,829,355
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$alvo/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$alvo/time-series/market_cap.tsv)  
Current Value: $1,445,829,355  
Daily Average: $2,491,442,550  
[--] Week: $1,445,829,355 -9.40%  
[--] Month: $1,445,829,355 -6.30%  
[--] Months: $1,445,829,355 -48%  
[--] Year: $1,445,829,355 -63%  
1-Year High: $3,916,245,932 on 2025-02-15  
1-Year Low: $1,427,133,285 on 2026-01-06  

### Top Alvotech Ordinary Shares Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"Comm'l-stage bio trading w/in 1.10X of their lows since 10/1/25 $VSTM LGSOC (ovarian) combo did $17.5MM in Q425 sales ($1MM beat) Should $OCUL have taken $16/sh last Sept $TLX $800MM FY25 sales $INSM $RYTM $ANIP $LGND $ALVO $CRSP $XERS $XNCR $SRPT $ACAD $ARGX $GMAB $XBI $IBB"  
[X Link](https://x.com/NightOwlBiotech/status/2022100929957498894) [@NightOwlBiotech](/creator/x/NightOwlBiotech) 2026-02-13T00:10Z [----] followers, [----] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing